NATPARA (parathyroid hormone)

Product NDC
68875-0203
11-digit product format
688750203
Labeler code
68875
Product ID
68875-0203_4e21ad11-e629-4a31-97ab-3c6f03703c47
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
PARATHYROID HORMONE
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Labeler
Takeda Pharmaceuticals America, Inc.
Application
BLA125511
Marketing category
BLA
Marketing start
2015-01-23
Marketing end
0000-00-00
Substance
PARATHYROID HORMONE
Active strength
50 ug/.08mL
Pharmacologic classes
Parathyroid Hormone [CS], Parathyroid Hormone [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68875-0203-1EA - Each68875-0203086c6dda-49e2-474d-8cff-f6cd2dd9da0a12015-10-02
68875-0203-2EA - Each68875-020346fe7a1e-6f65-4cf7-8932-7189451d26c312015-05-05

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68875-0203NATPARA (PARATHYROID HORMONE) (PARATHYROID HORMONE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TAKEDA PHARMACEUTICALS AMERICA, INC.]16Legacy NDC20230524_d11fba31-0a6c-11e3-8ffd-0800200c9a66.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68875-0203-2688750203022 CARTRIDGE in 1 CARTON (68875-0203-2) > 1.13 mL in 1 CARTRIDGE (68875-0203-1) 2 cartridge2015-01-230000-00-00NoNoCurrent